Awarded Maryland Nanobiotech Research Grant
ASR&D has been awarded research funding through the 2009 Maryland Nanobiotechnology Research and Industry Competition Grants. Twelve industry-leading research projects from the public and private sector received a one-time award for operating and capital funding. This is the first time Maryland has conducted a statewide nanobiotechnology research grants competition.
ASR&D was awarded this funding to lead research entitled "Acoustic Array Biosensor Utilizing Nanostructured Films for Multiplexed Point of Care Diagnosis of Infectious Agents" in collaboration with Temple University, Avianna Molecular & Technologies, and Drexel University
A excerpt of the release issued by the Maryland Department of Business & Economic Development can be viewed below.
Content from: marylandtedco.org
GOVERNOR ANNOUNCES $3 MILLION FOR NANOBIOTECH RESEARCH GRANTS
Funds to support 12 cutting-edge research projects, advance discoveries in science and medicine at the atomic level
BALTIMORE, MD (June 4, 2009) – Governor Martin O’Malley announced today the recipients of nearly $3 million in research funding through the 2009 Maryland Nanobiotechnology Research and Industry Competition Grants. Twelve industry-leading research projects from the public and private sector received a one-time award for operating and capital funding. This is the first time Maryland has conducted a statewide nanobiotechnology research grants competition. Nanobiotechnology is the revolutionary application of life sciences manufacturing, diagnostics, and delivery at the atomic level that has the potential to dramatically reshape the biotechnology industry.
“These grants are an important part of our long-term strategy for growing Maryland’s bioscience industry, creating jobs, and positioning Maryland as a national leader in bio and life sciences,” said Governor Martin O’Malley. “These 12 grants will provide critical funding to Maryland companies working to develop innovative life saving technologies for the treatment of cancer and diagnosis of infectious diseases.”
“I am pleased that the newly-created Maryland Biotechnology Center is already making a significant impact in our state’s life sciences enterprise with this $3 million in research funding,” said Christian S. Johansson, Secretary of DBED. “This investment in nanobiotechnology demonstrates Maryland’s commitment to supporting emerging technologies that will ultimately stimulate job creation and financial benefits in our state.”
DBED, through the MBC, and TEDCO jointly administered the nanotechnology grant competition. 103 applications were received in response to the competition’s solicitation with 43 finalists subject to technical reviews of their research proposals. A total of $3 million was available in the competition for research projects, up to $250,000 per grant. The 12 selected grant recipients are all Maryland-sited and include institutes of higher education, public and private; nonprofit organizations; and for-profit entities, including small businesses. Funding for this one-time research grant program to support nanobiotechnology research grants was provided through DBED. Last year, the General Assembly enacted the Coordinating Emerging Nanobiotechnology Research (CENTR) in Maryland program that authorizes TEDCO to provide future grants for nanobiotechnology research projects.
“This year’s one-time program is providing the Maryland science and technology community with an impressive amount of valuable data on this novel topic,” said Renée Winsky, president and executive director of TEDCO. “The interest we received in the grant competition validates the General Assembly’s establishment of The CENTR program in the TEDCO statute and I look forward to the progress and results that stem from this important research.”
To Continue reading the announcement click here.